Hepatitis B virus infection: epidemiology and vaccination.
暂无分享,去创建一个
Colin W Shepard | Lyn Finelli | E. Simard | L. Finelli | B. Bell | C. Shepard | A. Fiore | Edgar P Simard | Anthony E Fiore | Beth P Bell | Edgar P. Simard
[1] C. Teo,et al. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. , 1997, The Journal of infectious diseases.
[2] W. Braga,et al. [Prevalence of hepatitis B virus markers within household contacts in the State of Amazonas]. , 2003, Revista da Sociedade Brasileira de Medicina Tropical.
[3] J. Hadler,et al. FOLLOW‐UP OF INFANTS OF HEPATITIS B‐INFECTED WOMEN AFTER HEPATITIS B VACCINATION, CONNECTICUT, 1994 TO 1997 , 2000, The Pediatric infectious disease journal.
[4] T. Kurien,et al. Community prevalence of hepatitis B infection and modes of transmission in Tamil Nadu, India. , 2005, The Indian journal of medical research.
[5] D. Nalin. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality , 1994, The Yale Journal of Biology and Medicine.
[6] H. Reesink,et al. PREVENTION OF THE HBsAg CARRIER STATE IN NEWBORN INFANTS OF MOTHERS WHO ARE CHRONIC CARRIERS OF HBsAg AND HBeAg BY ADMINISTRATION OF HEPATITIS-B VACCINE AND HEPATITIS-B IMMUNOGLOBULIN Double-blind Randomised Placebo-controlled study , 1984, The Lancet.
[7] H. Balfour,et al. Transmission of hepatitis B virus in clinical laboratory areas. , 1979, Journal of Infectious Diseases.
[8] K. Ng,et al. Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia , 2005, Medical Microbiology and Immunology.
[9] F. André. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. , 1990, Vaccine.
[10] D. Vlahov,et al. Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. , 1995, American journal of epidemiology.
[11] H. Margolis,et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. , 1989, JAMA.
[12] J. Gerberding,et al. National, state, and urban area vaccination coverage among children aged 19-35 months--United States, 2005. , 2006, MMWR. Morbidity and mortality weekly report.
[13] E. Lewis,et al. Safety of neonatal hepatitis B vaccine administration. , 2001, The Pediatric infectious disease journal.
[14] H. Margolis,et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. , 1985, Pediatrics.
[15] Y. Hutin,et al. The global burden of disease attributable to contaminated injections given in health care settings , 2004, International journal of STD & AIDS.
[16] D. Greenberg. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies. , 1993, The Pediatric infectious disease journal.
[17] M. Favero,et al. Viral hepatitis B: aspects of environmental control. , 1977, Health laboratory science.
[18] P. Rhodes,et al. Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD). , 1998, Journal of clinical epidemiology.
[19] H. Margolis,et al. Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[20] B. McMahon,et al. Chronic hepatitis B , 2001, Hepatology.
[21] B. Bell,et al. Viral hepatitis transmission in ambulatory health care settings. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. , 1989, MMWR supplements.
[23] S. Greenland,et al. Factors Affecting Hepatitis Vaccination Refusal at a Sexually Transmitted Disease Clinic Among Men Who Have Sex With Men , 2003, Sexually transmitted diseases.
[24] R. Janssen,et al. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. , 2001, American journal of public health.
[25] Update: recommendations to prevent hepatitis B virus transmission--United States. , 1995, MMWR. Morbidity and mortality weekly report.
[26] H. Margolis,et al. The emergence of hepatitis B as a sexually transmitted disease. , 1990, The Medical clinics of North America.
[27] G. Yao,et al. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. , 1996, Gut.
[28] B. McMahon,et al. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. , 1990, Archives of internal medicine.
[29] I. Williams. Missed Opportunities for Hepatitis B Vaccination in Correctional Settings, Sexually Transmitted Disease (STD) Clinics, and Drug Treatment Programs , 2005 .
[30] M. I. Jirón,et al. Hepatitis B vaccine , 2016, Reactions Weekly.
[31] J. Banatvala,et al. Hepatitis B vaccine – do we need boosters? , 2003, Journal of viral hepatitis.
[32] R. Johnston,et al. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality , 1994 .
[33] Jerome I. Tokars,et al. Recommendations for preventing transmission of infections among chronic hemodialysis patients , 2001 .
[34] T R Bender,et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. , 1985, The Journal of infectious diseases.
[35] E. Schiff,et al. Recurrence and clearance of hepatitis B surface antigenemia in a dialysis patient infected with the human immunodeficiency virus. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] G. Da Villa,et al. Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness. , 1999, Vaccine.
[37] B. McMahon,et al. Chronic hepatitis B , 2001, Hepatology.
[38] Effectiveness of a middle school vaccination law--California, 1999-2001. , 2001, MMWR. Morbidity and mortality weekly report.
[39] H. Alter,et al. A "NEW" ANTIGEN IN LEUKEMIA SERA. , 1965, JAMA.
[40] M. Alter,et al. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States , 2006, Pediatrics.
[41] M. Shapiro,et al. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus , 1999, Hepatology.
[42] D. Vlahov,et al. Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. , 1994, Epidemiologic reviews.
[43] Ting‐Chen Chang,et al. Secular trend of age‐specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan , 2003, Journal of medical virology.
[44] M. Alter,et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[45] S. Hadler,et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. , 1991, The Journal of infectious diseases.
[46] H. Margolis,et al. Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection , 2002, Journal of medical virology.
[47] J P Mullooly,et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. , 2001, Pediatrics.
[48] D. Gretch,et al. Hepatitis B and transplantation. , 1995, Infectious disease clinics of North America.
[49] B. McMahon,et al. Duration of Hepatitis B Immunity in Low Risk Children Receiving Hepatitis B Vaccinations From Birth , 2004, The Pediatric infectious disease journal.
[50] H. Margolis,et al. Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. , 1992, The New England journal of medicine.
[51] E. Mast,et al. Preventing transmission of hepatitis B virus from people with chronic infection. , 2001, American journal of preventive medicine.
[52] Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). , 1991, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[53] D. Vlahov,et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. , 1996, American journal of public health.
[54] L. Barker,et al. National, state and urban-area vaccination-coverage levels among children aged 19-35 months, United States, 1999. , 2001, American journal of preventive medicine.
[55] Shou-Dong Lee,et al. Legend of hepatitis B vaccination: The Taiwan experience , 2004, Journal of gastroenterology and hepatology.
[56] T. Farley,et al. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana. , 1995, Pediatrics.
[57] J. Hoofnagle,et al. Serologic Diagnosis of Acute and Chronic Viral Hepatitis , 1991, Seminars in liver disease.
[58] C. Dentinger. Anti-HBs Persistence and Response to a Hepatitis B (HB) Vaccine Boost among Yup’ik Eskimos 23 Years after HB Vaccination , 2005 .
[59] C. Berg,et al. Hepatitis B virus infection among children born in the United States to Southeast Asian refugees. , 1989 .
[60] T. Farley,et al. The need for more aggressive follow-up of children born to hepatitis B surface antigen-positive mothers: lessons from the Louisiana Perinatal Hepatitis B Immunization Program. , 1996, The Pediatric infectious disease journal.
[61] Hepatitis B vaccination among high-risk adolescents and adults--San Diego, California, 1998-2001. , 2002, MMWR. Morbidity and mortality weekly report.
[62] H. Margolis,et al. Childhood hepatitis B virus infections in the United States before hepatitis B immunization. , 2001, Pediatrics.
[63] J. Waldon,et al. Recombinant DNA hepatitis B vaccination in teenagers: effect of a booster at 5 1/2 years. , 1992, The Journal of infectious diseases.
[64] J. Fonseca,et al. Prevalência de marcadores para o vírus da hepatite B em contatos domiciliares no Estado do Amazonas , 2003 .
[65] Petersen Nj,et al. Viral hepatitis B: aspects of environmental control. , 1977, Health laboratory science.
[66] Robert T. Chen,et al. Lack of Association Between Hepatitis B Birth Immunization and Neonatal Death: A Population-Based Study From the Vaccine Safety Datalink Project , 2004, The Pediatric infectious disease journal.
[67] R. Purcell,et al. Prevention of hepatitis B virus carriage of infants using HBV vaccine in Shanghai. Preliminary report of a randomized double-blind placebo-controlled trial. , 1985, Chinese Medical Journal.
[68] R. Beasley. Hepatitis B virus. The major etiology of hepatocellular carcinoma , 1988, Cancer.
[69] B. Bell,et al. A Large Outbreak of Hepatitis B Virus Infections Associated With Frequent Injections at a Physician's Office , 2005, Infection Control & Hospital Epidemiology.
[70] M. Alter,et al. Special Article: National Surveillance of Dialysis‐Associated Diseases in the United States, 2002 , 2005, Seminars in dialysis.
[71] S. Sherlock,et al. Role of hepatitis-B antigen carriers in non-parenteral transmission of the hepatitis-B virus. , 1974, Lancet.
[72] H. Margolis,et al. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. , 1999, American journal of public health.
[73] F. Mannelli,et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. , 2003, Vaccine.
[74] D. Francis,et al. Transmission of Hepatitis B Virus , 1981, Seminars in liver disease.
[75] D. West,et al. Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine. , 2001, Vaccine.
[76] H. Whittle,et al. HEPATITIS B VIRUS INFECTION IN TWO GAMBIAN VILLAGES , 1983, The Lancet.
[77] C. Chu,et al. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study , 1991, Hepatology.
[78] H. Coovadia,et al. The impact of the hepatitis B virus vaccine on the incidence of hepatitis B virus-associated membranous nephropathy. , 2003, Archives of pediatrics & adolescent medicine.
[79] H. Hsu,et al. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. , 2001, The Journal of pediatrics.
[80] Donna A. Almario,et al. Immunization Safety Review , 2002 .
[81] Lu-Yu Hwang,et al. HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.
[82] S. Hadler,et al. Occupational Risk of Hepatitis B Infection in Hospital Workers , 1985, Infection Control.
[83] A. Schuchat,et al. Prenatal screening for infectious diseases and opportunities for prevention. , 2003, Obstetrics and gynecology.
[84] M. Lai,et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.
[85] Pem Namgyal. Impact of hepatitis B immunization, Europe and worldwide. , 2003, Journal of hepatology.
[86] Morbidity and Mortality Weekly Report,et al. Prevention of Perinatal Transmission of Hepatitis B Virus: Prenatal Screening of all Pregnant Women for Hepatitis B Surface Antigen , 1989 .
[87] H. Inskip,et al. The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B. , 1992, The Journal of infectious diseases.
[88] Acute hepatitis B among children and adolescents--United States, 1990-2002. , 2004, MMWR. Morbidity and mortality weekly report.
[89] M. Favorov,et al. [The prevalence of the markers of viral hepatitis B and delta among the population in regions differing in the level of morbidity]. , 1992, Voprosy virusologii.
[90] Robert T. Chen,et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. , 2003, Archives of neurology.
[91] A. Green,et al. Horizontal transmission of hepatitis B virus , 1991, The Lancet.
[92] W. Williams,et al. Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission. , 2003, Pediatrics.
[93] S. Blank,et al. Predictors of Acceptance of Hepatitis B Vaccination in an Urban Sexually Transmitted Diseases Clinic , 2004, Sexually transmitted diseases.
[94] J. Ward. Hepatitis B vaccines , 1988, The New Zealand medical journal.
[95] H. Margolis,et al. Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines , 2004, The Pediatric infectious disease journal.
[96] H. Margolis,et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. , 2000, The Journal of infectious diseases.
[97] M. Lai,et al. Hepatitis B e antigen and antibody in asymptomatic Chinese with hepatitis B surface antigenemia in Taiwan , 2007, Gastroenterologia Japonica.
[98] M. Kane. Status of hepatitis B immunization programmes in 1998. , 1998, Vaccine.
[99] W. Szmuness,et al. Hepatitis-B antigen on environmental surfaces. , 1973 .
[100] M. Alter,et al. Hepatitis B Vaccination Coverage Levels Among Healthcare Workers in the United States, 2002-2003 , 2005, Infection Control & Hospital Epidemiology.
[101] B. McMahon,et al. Differences in Response to a Hepatitis B Vaccine Booster Dose Among Alaskan Children and Adolescents Vaccinated During Infancy , 2005, Pediatrics.
[102] H. Margolis,et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[103] A. Zanetti,et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study , 2005, The Lancet.
[104] Donna A. Almario,et al. Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders , 2002 .
[105] A. Lok,et al. Rapid and Sensitive Assays for Determination of Hepatitis B Virus (HBV) Genotypes and Detection of HBV Precore and Core Promoter Variants , 2003, Journal of Clinical Microbiology.
[106] W. Carman,et al. The clinical significance of surface antigen variants of hepatitis B virus , 1997, Journal of viral hepatitis.
[107] Horizontal transmission of hepatitis B virus , 1991 .
[108] B. McMahon,et al. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. , 1985, The Journal of infectious diseases.
[109] B. McMahon,et al. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. , 1992, The American journal of medicine.
[110] H. Margolis,et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. , 2002, The Journal of infectious diseases.
[111] S. Ellenberg,et al. Neonatal deaths after hepatitis B vaccine: the vaccine adverse event reporting system, 1991-1998. , 1999, Archives of pediatrics & adolescent medicine.
[112] C. Dolea,et al. World Health Organization , 1949, International Organization.
[113] N. Noah,et al. AN OUTBREAK OF HEPATITIS B FROM TATTOOING , 1979, The Lancet.
[114] H. Margolis,et al. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination , 2003, The Pediatric infectious disease journal.
[115] T. Strine,et al. Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage. , 2004, JAMA.
[116] Donna A. Almario,et al. IMMUNIZATION SAFETY REVIEW COMMITTEE , 2002 .
[117] Inda,et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.
[118] I. Mushahwar,et al. Viral hepatitis, type B. Studies on natural history and prevention re-examined. , 1979, The New England journal of medicine.
[119] W. Williams,et al. Impact of four urban perinatal hepatitis B prevention programs on screening and vaccination of infants and household members. , 2003, American journal of epidemiology.
[120] S. Kleinman,et al. Current and emerging infectious risks of blood transfusions. , 2003, JAMA.
[121] S. Marion,et al. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. , 1994, American journal of epidemiology.
[122] H. Whittle,et al. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. , 1999, Vaccine.
[123] E. Mast,et al. Hepatitis B vaccination coverage among United States children , 2001, The Pediatric infectious disease journal.
[124] M. Alter,et al. Hepatitis B virus transmission between heterosexuals. , 1986, JAMA.
[125] Thomas K. Hazlet,et al. Global Epidemiology of Hepatitis B Virus , 2004, Journal of clinical gastroenterology.
[126] H. Margolis,et al. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. , 1998, American journal of preventive medicine.
[127] G. Kent,et al. A large outbreak of acupuncture-associated hepatitis B. , 1988, American journal of epidemiology.
[128] S. Hadler,et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. , 1989, Vaccine.
[129] P. Bureau.. World Population Data Sheet of the Population Reference Bureau 2002 , 2002 .
[130] S. Kaneko,et al. Clearance of HBsAg in seven patients with chronic hepatitis B , 1992, Hepatology.
[131] K. Hyams. Risks of chronicity following acute hepatitis B virus infection: a review. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[132] K. Holmes,et al. Hepatitis B surface antigen (HBsAg) and antibody to HBsAg. Prevalence in homosexual and heterosexual men. , 1977, JAMA.
[133] Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term-care facilities--Mississippi, North Carolina, and Los Angeles County, California, 2003-2004. , 2005, MMWR. Morbidity and mortality weekly report.
[134] Y. Ko,et al. Trends in the incidence of hepatocellular carcinoma in boys and girls in Taiwan after large-scale hepatitis B vaccination. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[135] S. Stokley,et al. Factors associated with receiving hepatitis B vaccination among high-risk adults in the United States: an analysis of the National Health Interview Survey, 2000. , 2004, Family medicine.
[136] B. McMahon,et al. Prevalence of hepatitis B in selected Alaskan Eskimo villages. , 1983, American journal of epidemiology.
[137] E. Schiff,et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. , 1987, The New England journal of medicine.
[138] H. Hsu,et al. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan , 1999, Hepatology.
[139] D. Lin,et al. Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan. , 1998, Vaccine.
[140] B. McMahon,et al. Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus , 2001, Annals of Internal Medicine.
[141] C E Stevens,et al. The e antigen and vertical transmission of hepatitis B surface antigen. , 1977, American journal of epidemiology.
[142] S. Badur,et al. A Study of Serological Markers of Hepatitis B and C Viruses in Istanbul, Turkey , 2003, Medical Principles and Practice.